Loading data
HEINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 4.49 bn USD | 3.86 bn USD | 2.97 bn USD | 2.21 bn USD |
| Cost of revenue | 2.7 bn USD | 2.36 bn USD | 1.81 bn USD | 1.35 bn USD |
| Research and development expense | 120.94 m USD | 111.27 m USD | 95.77 m USD | 76.06 m USD |
| Selling, general and administrative expense | 767.47 m USD | 677.27 m USD | 528.15 m USD | 365.92 m USD |
| Operating profit | 1.02 bn USD | 824.46 m USD | 625.34 m USD | 496.84 m USD |
| Interest expense | — | — | 3.8 m USD | — |
| Profit before tax | 893.55 m USD | 677.59 m USD | 555.28 m USD | 491.02 m USD |
| Income tax expense | 148 m USD | 118.5 m USD | 110.9 m USD | 100.4 m USD |
| Net income (reported basis) | 690.39 m USD | 514.11 m USD | 403.6 m USD | 351.68 m USD |
| Basic earnings per share | 4.97 USD/share | 3.71 USD/share | 2.94 USD/share | 2.59 USD/share |
| Diluted earnings per share | 4.9 USD/share | 3.67 USD/share | 2.91 USD/share | 2.55 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.